NAFLD is a low-grade inflammatory chronic disease that the process of its occurrence and progression is accelerated by the high level of pro-inflammatory cytokines, including Interleukin‐1, TNF‐α, and Interleukin‐6 and the high level secretion of adipokines. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.